These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 39194256)

  • 1. Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.
    Lopera C; Monzó P; Aiello TF; Chumbita M; Peyrony O; Gallardo-Pizarro A; Pitart C; Cuervo G; Morata L; Bodro M; Herrera S; Del Río A; Martínez JA; Soriano A; Puerta-Alcalde P; Garcia-Vidal C
    Microbiol Spectr; 2024 Oct; 12(10):e0296123. PubMed ID: 39194256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
    Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
    Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
    Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
    Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
    J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and risk factors for recurrence in biliary source bloodstream infection episodes in oncological patients.
    Grafia I; Chumbita M; Seguí E; Cardozo C; Laguna JC; García de Herreros M; Garcia-Pouton N; Villaescusa A; Pitart C; Rico-Caballero V; Marco-Hernández J; Zamora C; Viladot M; Padrosa J; Tuca A; Mayor-Vázquez E; Marco F; Martínez JA; Mensa J; Garcia-Vidal C; Soriano A; Puerta-Alcalde P
    Microbiol Spectr; 2023 Aug; 11(5):e0214223. PubMed ID: 37610217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection.
    Pop-Vicas A; Tacconelli E; Gravenstein S; Lu B; D'Agata EM
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):325-31. PubMed ID: 19220162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant Gram-negative Bacterial Bloodstream Infections in Children's Hospitals in Japan, 2010-2017.
    Aizawa Y; Shoji T; Ito K; Kasai M; Sakurai H; Toyofuku E; Minami K; Hoshino T; Horikoshi Y
    Pediatr Infect Dis J; 2019 Jul; 38(7):653-659. PubMed ID: 30672891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli.
    Falcone M; Tiseo G; Dentali F; La Regina M; Foglia E; Gambacorta M; Garagiola E; Bonardi G; Clerici P; Colombo F; Farcomeni A; Concia E; Corrao S; Campanini M; Mazzone A
    Eur J Intern Med; 2018 Jul; 53():21-28. PubMed ID: 29426676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
    Litwin A; Fedorowicz O; Duszynska W
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L; Wang Y; Fan X; Tang W; Hu J
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Pathogenic Bacterial Spectrum, Drug Resistance and Risk Factors for Mortality of Bloodstream Infection in Patients with Hematologic Diseases].
    Guo Q; Wang XW; Chen XY; Zhao J; He SL; Tian WW; Ma LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1556-1562. PubMed ID: 37846716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
    Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
    Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.
    Thaden JT; Li Y; Ruffin F; Maskarinec SA; Hill-Rorie JM; Wanda LC; Reed SD; Fowler VG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes.
    Puerta-Alcalde P; Cardozo C; Marco F; Suárez-Lledó M; Moreno E; Morata L; Fernández-Avilés F; Gutiérrez-Garcia G; Chumbita M; Rosiñol L; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
    Bone Marrow Transplant; 2020 Mar; 55(3):603-612. PubMed ID: 31570779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
    Puerta-Alcalde P; Chumbita M; Charry P; Castaño-Díez S; Cardozo C; Moreno-García E; Marco F; Suárez-Lledó M; Garcia-Pouton N; Morata L; Fernández-Avilés F; Martínez-Roca A; Rodríguez G; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
    Transplant Cell Ther; 2021 Jun; 27(6):501.e1-501.e6. PubMed ID: 33891882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
    Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.
    Martinez-Nadal G; Puerta-Alcalde P; Gudiol C; Cardozo C; Albasanz-Puig A; Marco F; Laporte-Amargós J; Moreno-García E; Domingo-Doménech E; Chumbita M; Martínez JA; Soriano A; Carratalà J; Garcia-Vidal C
    Clin Infect Dis; 2020 Mar; 70(6):1068-1074. PubMed ID: 31321410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
    Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
    Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
    Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
    Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.